CORP-2 Trial: Colchicine effective in reducing the recurrence of pericarditis associated withconventional anti-inflammatory pattern.

Colchicine is effective in treating an acute pericarditis event and initial recurrences;however, there is no conclusive data on its efficacy and safety in the treatment of multiple recurrences. 

240patients were randomized to colchicine plus conventional anti-inflammatory scheme (aspirin, ibuprofen or indomethacin). The primary endpoint was the rate of recurrence of pericarditis in 18 months. The recurrence of pericarditis was 21.6% in the colchicine group and 42.5% in the placebo group (p = 0.0009) with 5 patients needed to treat. 

Conclusion

Colchicine added to conventional anti-inflammatory treatment reduced the rate of subsequent recurrences of pericarditis in patients with multiple recurrences. 

Article

Editorial

8_massimo_imazio_slides
Massimo Imazio
2014-03-31

Original title: Efficacy And Safety Of Colchicine In Patients With Multiple Recurrences of Pericarditis: Results of A Multicenter, Double-blind, Placebo-controlled, Randomized Study (CORP-2 Trial).

More articles by this author

Melody

The ducts of the right ventricle to the pulmonary artery are used in approximately 20 % of all patients with congenital defects including tetralogy...

Negative ultrasensitive troponin T values may help discriminate patients with chest pain in the emergency

New laboratory tests can detect minimally elevated  levels few hours before regarding detection methodologies of previous generations.The hypothesis of this study is that patients...

LAPLACE 2: Evolocumab effective in reducing LDL associated with statins

There are several patients who do not reach recommended LDL cholesterol despite maximally tolerated doses of statins levels.The Evolocumab is a monoclonal antibody that...

MADIT -CRT: Increased survival with resynchronization therapy plus defibrillator in patients with mild heart failure.

The MADIT -CRT study (Multicenter Automatic Defibrillator Implantation with Cardiac Resynchronization Therapy) had shown that early intervention with cardiac resynchronization therapy plus defibrillator in...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | Asymptomatic Severe Aortic Stenosis: What Should Be our Approach?

Approximately 3% of the population over 65 years old has aortic stenosis. Current guidelines recommend valve replacement for patients with symptoms or an ejection...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...